NONALCOHOLIC STEATOHEPATITIS - AN EXPANDED CLINICAL ENTITY

被引:899
作者
BACON, BR [1 ]
FARAHVASH, MJ [1 ]
JANNEY, CG [1 ]
NEUSCHWANDERTETRI, BA [1 ]
机构
[1] ST LOUIS UNIV,SCH MED,DEPT PATHOL,ST LOUIS,MO 63104
关键词
D O I
10.1016/0016-5085(94)90235-6
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: In the past, nonalcoholic steatohepatitis has been described mostly in obese women with diabetes. The aim of this study was to describe a series of patients with nonalcoholic steatohepatitis with a different clinical profile. Methods: The clinical, biochemical, and histological features of 33 patients with nonalcoholic steatohepatitis seen from July 1990 to June 1993 were analyzed. Results: The mean age was 47 years. All patients were antibody to hepatitis C virus-negative. Nineteen of 33 (58%) were men, 20 of 33 (61.%) were nonobese, 26 of 33 (79%) had normal glucose levels, and 26 of 33 (79%) had normal lipid levels. Fourteen of 33 (42%) had normal glucose and lipid levers and were not obese. Thirteen of 33 (39%) had pathological increases in fibrosis, 5 of whom had micronodular cirrhosis. Of these 13 with severe, progressive disease, 8 (62%) were women, 8 (62%) were obese, 4 (31%) were diabetic or had an elevated glucose level, and 3 (23%) had hyperlipidemia. Although serum iron studies (transferrin saturation and ferritin) were abnormal in 18 of 31 (58%), no patient had hemochromatosis. Conclusions: Nonalcoholic steatohepatitis can be a severe, progressive liver disease leading to the development of cirrhosis. It should no longer be considered a disease predominantly seen in obese women with diabetes.
引用
收藏
页码:1103 / 1109
页数:7
相关论文
共 28 条
[1]   FATTY LIVER HEPATITIS AND CIRRHOSIS IN OBESE PATIENTS [J].
ADLER, M ;
SCHAFFNER, F .
AMERICAN JOURNAL OF MEDICINE, 1979, 67 (05) :811-816
[2]   HLA TYPING IN IDIOPATHIC HEMOCHROMATOSIS - DISTINCTION BETWEEN HOMOZYGOTES AND HETEROZYGOTES WITH BIOCHEMICAL EXPRESSION [J].
BASSETT, ML ;
HALLIDAY, JW ;
POWELL, LW .
HEPATOLOGY, 1981, 1 (02) :120-126
[3]   VALUE OF HEPATIC IRON MEASUREMENTS IN EARLY HEMOCHROMATOSIS AND DETERMINATION OF THE CRITICAL IRON LEVEL ASSOCIATED WITH FIBROSIS [J].
BASSETT, ML ;
HALLIDAY, JW ;
POWELL, LW .
HEPATOLOGY, 1986, 6 (01) :24-29
[4]   USEFULNESS AND LIMITATIONS OF LABORATORY AND HEPATIC IMAGING STUDIES IN IRON-STORAGE DISEASE [J].
BONKOVSKY, HL ;
SLAKER, DP ;
BILLS, EB ;
WOLF, DC .
GASTROENTEROLOGY, 1990, 99 (04) :1079-1091
[5]  
CLAIN DJ, 1987, GASTROENTEROL CLIN N, V16, P239
[6]  
DEAUGINER YM, 1993, HEPATOLOGY, V17, P30
[7]  
DIANZANI MU, 1991, BIOCH ASPECTS FATTY, P327
[8]   MEASUREMENTS OF IRON STATUS IN PATIENTS WITH CHRONIC HEPATITIS [J].
DIBISCEGLIE, AM ;
AXIOTIS, CA ;
HOOFNAGLE, JH ;
BACON, BR .
GASTROENTEROLOGY, 1992, 102 (06) :2108-2113
[9]   ALCOHOL-LIKE LIVER-DISEASE IN NONALCOHOLICS - A CLINICAL AND HISTOLOGIC COMPARISON WITH ALCOHOL-INDUCED LIVER-INJURY [J].
DIEHL, AM ;
GOODMAN, Z ;
ISHAK, KG .
GASTROENTEROLOGY, 1988, 95 (04) :1056-1062
[10]   INHIBITION OF ETHANOL AND CARBON TETRACHLORIDE INDUCED FATTY LIVER BY ANTIOXIDANTS [J].
DILUZIO, NR ;
COSTALES, F .
EXPERIMENTAL AND MOLECULAR PATHOLOGY, 1965, 4 (02) :141-&